Literature DB >> 19345087

Emerging pathogenic pathways in the spinocerebellar ataxias.

Kerri M Carlson1, J Michael Andresen, Harry T Orr.   

Abstract

The spinocerebellar ataxias (SCAs) are diseases characterized by neurodegeneration of the spinocerebellum. To date, 28 autosomal dominant SCAs have been described and seventeen causative genes identified. These genes play a role in a broad range of cellular processes. Recent studies focused on the wild type and pathogenic functions of these genes implicate both gene expression and glutamate-dependent and calcium-dependent neuronal signaling as important pathways leading to cerebellar dysfunction. Understanding how these genes cause disease will allow a deeper understanding of the cerebellum in particular as well as neurodegenerative disease in general.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19345087      PMCID: PMC2721007          DOI: 10.1016/j.gde.2009.02.009

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  47 in total

Review 1.  Rush hour at the promoter: how the ubiquitin-proteasome pathway polices the traffic flow of nuclear receptor-dependent transcription.

Authors:  Andrew P Dennis; Bert W O'Malley
Journal:  J Steroid Biochem Mol Biol       Date:  2005-02-05       Impact factor: 4.292

Review 2.  Diseases of unstable repeat expansion: mechanisms and common principles.

Authors:  Jennifer R Gatchel; Huda Y Zoghbi
Journal:  Nat Rev Genet       Date:  2005-10       Impact factor: 53.242

3.  An autosomal dominant cerebellar ataxia linked to chromosome 16q22.1 is associated with a single-nucleotide substitution in the 5' untranslated region of the gene encoding a protein with spectrin repeat and Rho guanine-nucleotide exchange-factor domains.

Authors:  Kinya Ishikawa; Shuta Toru; Taiji Tsunemi; Mingshun Li; Kazuhiro Kobayashi; Takanori Yokota; Takeshi Amino; Kiyoshi Owada; Hiroto Fujigasaki; Masaki Sakamoto; Hiroyuki Tomimitsu; Minoru Takashima; Jiro Kumagai; Yoshihiro Noguchi; Yoshiyuki Kawashima; Norio Ohkoshi; Gen Ishida; Manabu Gomyoda; Mari Yoshida; Yoshio Hashizume; Yuko Saito; Shigeo Murayama; Hiroshi Yamanouchi; Toshio Mizutani; Ikuko Kondo; Tatsushi Toda; Hidehiro Mizusawa
Journal:  Am J Hum Genet       Date:  2005-07-06       Impact factor: 11.025

4.  An integrative approach to gain insights into the cellular function of human ataxin-2.

Authors:  Markus Ralser; Mario Albrecht; Ute Nonhoff; Thomas Lengauer; Hans Lehrach; Sylvia Krobitsch
Journal:  J Mol Biol       Date:  2004-12-10       Impact factor: 5.469

5.  Polyglutamine-expanded spinocerebellar ataxia-7 protein disrupts normal SAGA and SLIK histone acetyltransferase activity.

Authors:  Stacey J McMahon; Marilyn G Pray-Grant; David Schieltz; John R Yates; Patrick A Grant
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-02       Impact factor: 11.205

6.  Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration.

Authors:  Vikas B Palhan; Shiming Chen; Guang-Hua Peng; Agneta Tjernberg; Armin M Gamper; Yuxin Fan; Brian T Chait; Albert R La Spada; Robert G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-02       Impact factor: 11.205

Review 7.  Linking the ubiquitin-proteasome pathway to chromatin remodeling/modification by nuclear receptors.

Authors:  H K Kinyamu; J Chen; T K Archer
Journal:  J Mol Endocrinol       Date:  2005-04       Impact factor: 5.098

8.  Autosomal dominant congenital non-progressive ataxia overlaps with the SCA15 locus.

Authors:  T E Dudding; K Friend; P W Schofield; S Lee; I A Wilkinson; R I Richards
Journal:  Neurology       Date:  2004-12-28       Impact factor: 9.910

9.  Gene profiling links SCA1 pathophysiology to glutamate signaling in Purkinje cells of transgenic mice.

Authors:  Heliane G Serra; Courtney E Byam; Jeffrey D Lande; Susan K Tousey; Huda Y Zoghbi; Harry T Orr
Journal:  Hum Mol Genet       Date:  2004-08-18       Impact factor: 6.150

10.  Polyglutamine expansion reduces the association of TATA-binding protein with DNA and induces DNA binding-independent neurotoxicity.

Authors:  Meyer J Friedman; Chuan-En Wang; Xiao-Jiang Li; Shihua Li
Journal:  J Biol Chem       Date:  2008-01-24       Impact factor: 5.157

View more
  41 in total

Review 1.  Developments in RNA splicing and disease.

Authors:  Michael G Poulos; Ranjan Batra; Konstantinos Charizanis; Maurice S Swanson
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

2.  KCNC3(R420H), a K(+) channel mutation causative in spinocerebellar ataxia 13 displays aberrant intracellular trafficking.

Authors:  Carolina Gallego-Iradi; Justin S Bickford; Swati Khare; Alexis Hall; Jerelyn A Nick; Donya Salmasinia; Kolja Wawrowsky; Serguei Bannykh; Duong P Huynh; Diego E Rincon-Limas; Stefan M Pulst; Harry S Nick; Pedro Fernandez-Funez; Michael F Waters
Journal:  Neurobiol Dis       Date:  2014-08-22       Impact factor: 5.996

3.  Prodynorphin mutations cause the neurodegenerative disorder spinocerebellar ataxia type 23.

Authors:  Georgy Bakalkin; Hiroyuki Watanabe; Justyna Jezierska; Cloë Depoorter; Corien Verschuuren-Bemelmans; Igor Bazov; Konstantin A Artemenko; Tatjana Yakovleva; Dennis Dooijes; Bart P C Van de Warrenburg; Roman A Zubarev; Berry Kremer; Pamela E Knapp; Kurt F Hauser; Cisca Wijmenga; Fred Nyberg; Richard J Sinke; Dineke S Verbeek
Journal:  Am J Hum Genet       Date:  2010-10-28       Impact factor: 11.025

4.  Targeted next-generation sequencing of a 12.5 Mb homozygous region reveals ANO10 mutations in patients with autosomal-recessive cerebellar ataxia.

Authors:  Sascha Vermeer; Alexander Hoischen; Rowdy P P Meijer; Christian Gilissen; Kornelia Neveling; Nienke Wieskamp; Arjan de Brouwer; Michel Koenig; Mathieu Anheim; Mirna Assoum; Nathalie Drouot; Slobodanka Todorovic; Vedrana Milic-Rasic; Hanns Lochmüller; Giovanni Stevanin; Cyril Goizet; Albert David; Alexandra Durr; Alexis Brice; Berry Kremer; Bart P C van de Warrenburg; Mascha M V A P Schijvenaars; Angelien Heister; Michael Kwint; Peer Arts; Jenny van der Wijst; Joris Veltman; Erik-Jan Kamsteeg; Hans Scheffer; Nine Knoers
Journal:  Am J Hum Genet       Date:  2010-11-18       Impact factor: 11.025

Review 5.  Machado-Joseph Disease: from first descriptions to new perspectives.

Authors:  Conceição Bettencourt; Manuela Lima
Journal:  Orphanet J Rare Dis       Date:  2011-06-02       Impact factor: 4.123

6.  Consensus and controversies in best practices for molecular genetic testing of spinocerebellar ataxias.

Authors:  Jorge Sequeiros; Sara Seneca; Joanne Martindale
Journal:  Eur J Hum Genet       Date:  2010-02-24       Impact factor: 4.246

7.  A conserved eEF2 coding variant in SCA26 leads to loss of translational fidelity and increased susceptibility to proteostatic insult.

Authors:  Katherine E Hekman; Guo-Yun Yu; Christopher D Brown; Haipeng Zhu; Xiaofei Du; Kristina Gervin; Dag Erik Undlien; April Peterson; Giovanni Stevanin; H Brent Clark; Stefan M Pulst; Thomas D Bird; Kevin P White; Christopher M Gomez
Journal:  Hum Mol Genet       Date:  2012-09-21       Impact factor: 6.150

Review 8.  Cellular and circuit mechanisms underlying spinocerebellar ataxias.

Authors:  Pratap Meera; Stefan M Pulst; Thomas S Otis
Journal:  J Physiol       Date:  2016-06-12       Impact factor: 5.182

9.  Functional effects of spinocerebellar ataxia type 13 mutations are conserved in zebrafish Kv3.3 channels.

Authors:  Allan F Mock; Jessica L Richardson; Jui-Yi Hsieh; Gina Rinetti; Diane M Papazian
Journal:  BMC Neurosci       Date:  2010-08-16       Impact factor: 3.288

Review 10.  Polyglutamine spinocerebellar ataxias - from genes to potential treatments.

Authors:  Henry L Paulson; Vikram G Shakkottai; H Brent Clark; Harry T Orr
Journal:  Nat Rev Neurosci       Date:  2017-08-17       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.